TickerFactsScreenerDevelopers

Voyager Therapeutics, Inc. (VYGR) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2013: $135.0K2014: $7.04M2015: $31.31M2016: $36.64M2017: $31.53M2018: $46.86M2019: $86.04M2020: $104.44M2021: $117.43M2022: $98.96M2023: $68.80M2024: $71.37M2025: $65.30M$65.30M
2013Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$65.30M-8.5%
2024$71.37M+3.7%
2023$68.80M-30.5%
2022$98.96M-15.7%
2021$117.43M+12.4%
2020$104.44M+21.4%
2019$86.04M+83.6%
2018$46.86M+48.6%
2017$31.53M-13.9%
2016$36.64M+17.0%
2015$31.31M+345.0%
2014$7.04M+5111.1%
2013$135.0K—